Riskpilot← Back to searchSign inGet full accessRenQMed Consulting AB
ABActiveOrg 5590905864Fjelie Prästgårdsväg 1All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 20160 employees
Revenue 2024
SEK 341K
+24% vs 2023
EBITDA margin
63.9%
+8% vs 2023
Equity ratio
57.0%
Financial strength
Net profit 2024
SEK 173K
+8% vs 2023
| Revenue | SEK 341K | +24% |
| EBITDA | SEK 218K | +8% |
| Net profit | SEK 173K | +8% |
| Total assets | SEK 391K | -16% |
| Equity | SEK 223K | +6% |
| Employees | 0 | — |
Legal name
RenQMed Consulting AB
Org number
5590905864
Legal form
Aktiebolag
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
13 december 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom medicinsk och klinisk riskhantering, patientsäkerhet, kvalitet, medicinsk utbildning, läkarvård inom öppen och sluten vård, och därmed förenlig verksamhet.
Address
Fjelie Prästgårdsväg 1
Email
renqmed@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 368 | 282 | 222 | 274 | 341 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 256 | 167 | 152 | 202 | 218 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 256 | 167 | 152 | 202 | 218 |
| Net financials | — | — | — | — | — |
| Profit before tax | 256 | 166 | 152 | 202 | 218 |
| Tax | −55 | −34 | −31 | −42 | −45 |
| Net profit | 201 | 132 | 121 | 160 | 173 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 414 | 333 | 237 | 467 | 391 |
| Equity | 253 | 185 | 174 | 211 | 223 |
| Long-term debt | 51 | 55 | 15 | 51 | 103 |
| Short-term debt | 110 | 93 | 48 | 206 | 65 |
| Total debt | 161 | 148 | 63 | 257 | 168 |
EBITDA margin
63.9%
This company
15.8%
Market median
+304% vs market
20202024
Equity ratio
57.0%
This company
38.2%
Market median
+49% vs market
20202024
Return on equity
77.6%
This company
18.4%
Market median
+322% vs market
20202024
Net profit margin
50.7%
This company
8.1%
Market median
+526% vs market
20202024
Asset turnover
0.87×
This company
1.12×
Market median
+22% vs market
20202024
Debt / equity
0.75×
This company
0.62×
Market median
+21% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EK Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RenQMed Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emma Katarina Louise Treschow | Deputy Chief Executive Officer | 0 companies |
| Astrid Maria Alquist Hegbrant | Chairman | 0 companies |
| Sara Alexandra Caroline Alquist | Deputy Board Member | 0 companies |